Cargando…

Pancreatic cancer stemness: dynamic status in malignant progression

Pancreatic cancer (PC) is one of the most aggressive malignancies worldwide. Increasing evidence suggests that the capacity for self-renewal, proliferation, and differentiation of pancreatic cancer stem cells (PCSCs) contribute to major challenges with current PC therapies, causing metastasis and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yutong, Qin, Cheng, Zhao, Bangbo, Wang, Yuanyang, Li, Zeru, Li, Tianyu, Yang, Xiaoying, Wang, Weibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182699/ https://www.ncbi.nlm.nih.gov/pubmed/37173787 http://dx.doi.org/10.1186/s13046-023-02693-2

Ejemplares similares

EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway
por: Wang, Yuanyang, et al.
Publicado: (2023)

STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation
por: Qin, Cheng, et al.
Publicado: (2023)

CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway
por: Qin, Cheng, et al.
Publicado: (2022)

DHX38 restricts chemoresistance by regulating the alternative pre-mRNA splicing of RELL2 in pancreatic ductal adenocarcinoma
por: Li, Zeru, et al.
Publicado: (2023)

Long Noncoding RNA and Circular RNA: Two Rising Stars in Regulating Epithelial-Mesenchymal Transition of Pancreatic Cancer
por: Yang, Xiaoying, et al.
Publicado: (2022)

Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs
por: Zhao, Bangbo, et al.
Publicado: (2022)

Chromatin Dynamics in Digestive System Cancer: Commander and Regulator
por: Li, Zeru, et al.
Publicado: (2022)

Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas
por: Zhao, Bangbo, et al.
Publicado: (2021)

Duodenal descending part-jejunum intussusception and upper gastrointestinal bleeding caused by duodenal fibrolipoma: a case report
por: Zhao, Bangbo, et al.
Publicado: (2019)

A novel prognostic marker and immunogenic membrane antigen: prohibitin (PHB) in pancreatic cancer
por: Wang, Weibin, et al.
Publicado: (2018)

High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID-19 patients
por: Qin, Cheng, et al.
Publicado: (2020)

Review of the possible association between thyroid and breast carcinoma
por: Dong, Liangbo, et al.
Publicado: (2018)

Distinguishing Coronavirus Disease 2019 Patients From General Surgery Emergency Patients With the CIAAD Scale: Development and Validation of a Prediction Model Based on 822 Cases in China
por: Zhao, Bangbo, et al.
Publicado: (2021)

Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic
por: Du, Yongxing, et al.
Publicado: (2017)

Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study
por: Zhou, Xingtong, et al.
Publicado: (2020)

The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions
por: Li, Jindan, et al.
Publicado: (2023)

Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression
por: Chen, Kai, et al.
Publicado: (2021)

Resveratrol Ameliorates the Malignant Progression of Pancreatic Cancer by Inhibiting Hypoxia-induced Pancreatic Stellate Cell Activation
por: Xiao, Ying, et al.
Publicado: (2020)

Metabolism of pancreatic cancer: paving the way to better anticancer strategies
por: Qin, Cheng, et al.
Publicado: (2020)

Current status of and progress in the treatment of malignant pleural effusion of lung cancer
por: Zhao, Yuhua, et al.
Publicado: (2023)

Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
por: Lee, Myoung Woo, et al.
Publicado: (2019)

MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3
por: Tian, Tingke, et al.
Publicado: (2021)

The cell cycle gene centromere protein K (CENPK) contributes to the malignant progression and prognosis of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2022)

Heterogeneous Pancreatic Stellate Cells Are Powerful Contributors to the Malignant Progression of Pancreatic Cancer
por: Zhang, Zhilin, et al.
Publicado: (2021)

Unbalanced YAP–SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma
por: Wang, Lianghai, et al.
Publicado: (2018)

Current status and progress in immunotherapy for malignant pleural mesothelioma
por: Sun, Boyang, et al.
Publicado: (2022)

High expression of RAB38 promotes malignant progression of pancreatic cancer
por: Li, Bao-Yu, et al.
Publicado: (2019)

MicroRNA-190b expression predicts a good prognosis and attenuates the malignant progression of pancreatic cancer by targeting MEF2C and TCF4
por: Li, Yunwei, et al.
Publicado: (2022)

The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma
por: Liu, Zhiyuan, et al.
Publicado: (2023)

Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma
por: Wang, Yunchao, et al.
Publicado: (2017)

Genomic characterization of malignant progression in neoplastic pancreatic cysts
por: Noë, Michaël, et al.
Publicado: (2020)

Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy
por: Zhao, Xia, et al.
Publicado: (2013)

Progress of pyroptosis in acute pancreatitis
por: Li, Hong-Yao, et al.
Publicado: (2021)

Role of microenvironmental periostin in pancreatic cancer progression
por: Liu, Yang, et al.
Publicado: (2016)

An Overview of Epigenetic Methylation in Pancreatic Cancer Progression
por: Zhao, Yuhao, et al.
Publicado: (2022)

Amino acids in hematologic malignancies: Current status and future perspective
por: Wang, Mengyao, et al.
Publicado: (2023)

Glutathione S-Transferase Mu-3 Predicts a Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer
por: Wang, Shunda, et al.
Publicado: (2020)

Prognostic factors and Doxorubicin involved in malignant progression of meningioma
por: Huo, Xulei, et al.
Publicado: (2023)

The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis
por: Wang, Li, et al.
Publicado: (2022)

Construction of a QSAR Model Based on Flavonoids and Screening of Natural Pancreatic Lipase Inhibitors
por: Yuan, Yutong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l8i7u4600qa8ivho863157364n